Literature DB >> 24981690

Extensive toxic epidermal necrolysis following brentuximab vedotin administration.

Maria Ilaria Del Principe1, Giuseppe Sconocchia, Francesco Buccisano, Mariagiovanna Cefalo, Ambra Di Veroli, Giovanna De Santis, Daniela Nasso, Luca Maurillo, Lucia Anemona, Massimiliano Postorino, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24981690     DOI： 10.1007/s00277-014-2148-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  SEVERE INSULIN RESISTANCE WITH DIABETIC KETOACIDOSIS AFTER BRENTUXIMAB TREATMENT.

Authors:  Janet M Chiang; Andrew R Lai; Mark Anderson; Robert J Rushakoff
Journal:  AACE Clin Case Rep       Date:  2020-01-22

Review 2.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.